The company markets products under the brand name Ahngook. Ahn-gook Pharm is headquartered in Seoul, South Korea. For a complete picture of Amlodipine + indapamide + valsartan’s drug-specific PTSR and ...

but less with valsartan than with amlodipine, particularly during the first 6 months. The two groups did not differ in the primary composite endpoint of adverse cardiovascular events. However ...

OBJECTIVE: To examine in patients treated with a regimen including single-pill combinations (SPCs) of amlodipine/valsartan (1) blood pressure (BP) reduction and control, total cardiovascular risk ...

Other than having high blood pressure, I am healthy, eat a Mediterranean-style diet, and exercise most days. Since 2021, I have been taking one tab of amlodipine/valsartan daily with blood pressure ...

Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments, has unveiled ...

Globalpharma, the UAE's leading Pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has ...

As the pharmaceutical sector continues to grow, the group is strategically positioning Globalpharma to capitalise on emerging ...

He added. The momentum for 2025 builds on the success of 2024, which has seen the launch of several innovative products. These include Glovadip (Valsartan + Amlodipine) and RUSET (Rosuvastatin + ...

28,29 In view of the disproportionate elevation of central aortic pressures in patients with systolic hypertension and stiffened arteries, we were interested to determine whether the novel angiotensin ...

However, they are also possible therapeutic agents due to their potentially beneficial physiological effects. The angiotensin receptor–neprilysin inhibitor, sacubitril/valsartan, simultaneously ...

Soon after, other combinations were being tested in the clinic, such as ACE inhibitors and diurectics (lisinopril and hydrochlorothiazide); ARBs and diuretics (losartan or valsartan and ...